First Time Loading...

IDT Australia Ltd
ASX:IDT

Watchlist Manager
IDT Australia Ltd Logo
IDT Australia Ltd
ASX:IDT
Watchlist
Price: 0.091 AUD -4.21% Market Closed
Updated: May 3, 2024

IDT Australia Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

IDT Australia Ltd
Revenue Peer Comparison

Comparables:
MYX
NEU
BOT
PBP
C
CU6

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
IDT Australia Ltd
ASX:IDT
Revenue
AU$10.4m
CAGR 3-Years
-7%
CAGR 5-Years
-7%
CAGR 10-Years
-5%
Mayne Pharma Group Ltd
ASX:MYX
Revenue
AU$190.3m
CAGR 3-Years
-25%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
Neuren Pharmaceuticals Ltd
ASX:NEU
Revenue
AU$237.6m
CAGR 3-Years
550%
CAGR 5-Years
77%
CAGR 10-Years
47%
Botanix Pharmaceuticals Ltd
ASX:BOT
Revenue
AU$588.4k
CAGR 3-Years
56%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Probiotec Ltd
ASX:PBP
Revenue
AU$221.2m
CAGR 3-Years
28%
CAGR 5-Years
24%
CAGR 10-Years
13%
C
Clarity Pharmaceuticals Ltd
ASX:CU6
Revenue
AU$11.7m
CAGR 3-Years
59%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is IDT Australia Ltd's Revenue?
Revenue
10.4m AUD

Based on the financial report for Dec 31, 2023, IDT Australia Ltd's Revenue amounts to 10.4m AUD.

What is IDT Australia Ltd's Revenue growth rate?
Revenue CAGR 10Y
-5%

Over the last year, the Revenue growth was 73%. The average annual Revenue growth rates for IDT Australia Ltd have been -7% over the past three years , -7% over the past five years , and -5% over the past ten years .